financetom
Business
financetom
/
Business
/
GRAPHIC-Tesla's bumpy ride, captured in five charts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GRAPHIC-Tesla's bumpy ride, captured in five charts
Apr 5, 2024 9:07 AM

April 5 (Reuters) - Tesla's reported move to

scrap plans for a low-cost car marks the latest disappointment

for investors who have dumped shares of the automaker this year

on worries over slowing demand, an aging vehicle line-up and

rising Chinese competition.

Reuters reported earlier on Friday that Tesla has canceled

the long-promised inexpensive car but will continue developing

self-driving robotaxis on the same small-vehicle platform.

Shares of the electric-vehicle maker fell 4.7% on the news.

They were already down nearly 32% this year, as of last close,

making them among the worst performers on the S&P 500 index.

Here are five charts on Tesla's rocky ride in 2024:

MAGNIFICENT SEVEN LAGGARD

This year's slump in Tesla stock has threatened its place in

an elite grouping of companies that powered a surge in U.S.

markets in recent years, several market experts have said.

The so-called "Magnificent Seven" consists of Apple ( AAPL )

, Microsoft ( MSFT ), Amazon.com ( AMZN ), Alphabet

, Meta Platforms ( META ), Nvidia ( NVDA ) and Tesla.

But Tesla is no longer looking so magnificent, and some

analysts say AI-linked names such as Advanced Micro Devices ( AMD )

or Broadcom ( AVGO ) might be more appropriate as part

of that group of big market gainers.

SINKING MARKET VALUE

Tesla has lost more than $250 billion in market value this

year. While it remains the world's most valuable automaker,

Toyota Motor ( TM ) is slowly narrowing the gap as the

Japanese company rides a boom in demand for hybrid vehicles.

Toyota's ( TM ) shares have risen nearly 40% this year, pushing its

market value up by around $80 billion. But some analysts have

warned Toyota ( TM ) remains a laggard in pure battery EVs, which are

widely viewed as the long-term future of the auto industry.

At its peak in late 2021, Tesla's market cap surpassed more

than $1 trillion in value, but the stock has lost more than half

its value since then.

DELIVERIES SLUMP

Tesla posted a decline in quarterly deliveries for the first

time since the second quarter of 2020, when the COVID-19

pandemic shut down a significant amount of production at its

factories.

Analysts have said that the effects of Tesla's

margin-sapping price cuts to boost demand have been waning with

the company producing many more vehicles than it is handing over

to customers.

GLOBAL AUTOMAKERS SALES TOWER TESLA'S

Automakers such as Volkswagen, Toyota ( TM ) and Honda sold far

more vehicles than Tesla in 2023, yet the EV maker's market

capitalization eclipses that of Toyota ( TM ), Mercedes-Benz and

Porsche combined.

MUSK'S PERSONA POLARIZES WOULD-BE BUYERS

The number of would-be Tesla buyers in the U.S. is

shrinking, according to a survey by market intelligence firm

Caliber, which attributed the drop in part to CEO Elon Musk's

polarizing persona.

Caliber's "consideration score" for Tesla fell to 31% in

February, less than half its high of 70% in November 2021 when

it started tracking consumer interest in the brand.

Reuters spoke to five marketing, polling and car experts who

said controversies surrounding Musk's increasingly right-wing

politics and public statements are weighing on Tesla's brand and

demand.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved